RNS Number : 7489O
Legal & General UCITS ETF PLC
03 June 2020
| Funds |
Date |
ISIN code |
Shares in Issue |
Currency |
Net Asset Value |
NAV/per share Base |
| L&G US Equity UCITS ETF |
02/06/2020 |
IE00BFXR5Q31 |
11767267 |
USD |
135683847.68 |
11.531 |
| L&G UK Equity UCITS ETF |
02/06/2020 |
IE00BFXR5R48 |
1200000 |
GBP |
11049390.93 |
9.208 |
| L&G Global Equity UCITS ETF |
02/06/2020 |
IE00BFXR5S54 |
2900000 |
USD |
32229534.33 |
11.114 |
| L&G Japan Equity UCITS ETF |
02/06/2020 |
IE00BFXR5T61 |
10745000 |
USD |
112815356.69 |
10.499 |
| L&G Europe ex UK Equity UCITS ETF |
02/06/2020 |
IE00BFXR5V83 |
9260988 |
EUR |
97370746.41 |
10.514 |
| L&G Asia Pacific ex Japan Equity UCITS ETF |
02/06/2020 |
IE00BFXR5W90 |
4405639 |
USD |
44260600.99 |
10.046 |
| L&G Clean Water UCITS ETF |
02/06/2020 |
IE00BK5BC891 |
1450000 |
USD |
15126399.10 |
10.432 |
| L&G Artificial Intelligence UCITS ETF |
02/06/2020 |
IE00BK5BCD43 |
5400000 |
USD |
64682056.24 |
11.978 |
| L&G Healthcare Innovation UCITS ETF |
02/06/2020 |
IE00BK5BC677 |
2400000 |
USD |
29462384.82 |
12.276 |
| L&G Pharma Breakthrough UCITS ETF |
02/06/2020 |
IE00BF0H7608 |
2400000 |
USD |
28623814.63 |
11.927 |
| L&G Europe Equity (Responsible Exclusions) UCITS ETF |
02/06/2020 |
IE00BKLTRN76 |
9200000 |
EUR |
92390083.07 |
10.042 |
| L&G US Equity (Responsible Exclusions) UCITS ETF |
02/06/2020 |
IE00BKLWY790 |
57400000 |
USD |
593466390.63 |
10.339 |
| L&G Battery Value-Chain UCITS ETF |
02/06/2020 |
IE00BF0M2Z96 |
11400000 |
USD |
101394650.19 |
8.894 |
| L&G Ecommerce Logistics UCITS ETF |
02/06/2020 |
IE00BF0M6N54 |
5100000 |
USD |
52450342.42 |
10.284 |
| L&G ROBO Global Robotics and Automation UCITS ETF |
02/06/2020 |
IE00BMW3QX54 |
46430616 |
USD |
801451672.99 |
17.261 |
| L&G Cyber Security UCITS ETF |
02/06/2020 |
IE00BYPLS672 |
82586776 |
USD |
1526037090.66 |
18.478 |
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
NAVZZGGVZZKGGZZ
